E
Evident Vascular
A company developing an advanced intravascular ultrasound (IVUS) platform technology
About Evident Vascular
Evident Vascular is a medical device company that has developed an intravascular ultrasound (IVUS) platform. This platform utilizes artificial intelligence to provide high-quality imaging for peripheral and coronary vascular procedures.
The company's business model is centered on the development and sale of this advanced IVUS platform to hospitals and clinics that perform vascular interventions. The target market includes interventional cardiologists, radiologists, and vascular surgeons. By providing a superior imaging solution, Evident Vascular aims to improve patient outcomes and procedural efficiency.
Evident Vascular has a strong leadership team with experience in the medical device industry. The company has also secured Series B financing, which will be used to advance the development and commercialization of its AI-powered IVUS platform.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- San Jose, United States
- Employees
- 38
- Open positions
- None listed
- Dealroom signal
- 83.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Medical Imaging, AI for medical imaging, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2025 | — | — | Vensana Capital · ShangBay Capital | ↗ |
| SERIES A✓Equity / VC | Oct 2023 | $35M | $140M | Vensana Capital | ↗ |
Growth signals
Latest recorded traffic for Evident Vascular is 1.2K monthly website visits, down 29.4% over the last three months. Evident Vascular's team grew 18.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Vensana Capital
ShangBay Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evident Vascular on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evident Vascular’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






